Colomeb135 mg

Mebeverine is indicated for the: Symptomatic treatment of irritable bowel syndrome (IBS) Chronic irritable colon Spastic constipation Mucous colitis Colicky abdominal pain Persistent non-specific diarrhoea

Anticholinergics

Mebeverine is a musculotropic antispasmodic agent used to relieve cramps or spasms of the stomach and intestine (gut). It is particularly useful in treating Irritable Bowel Syndrome (IBS) and similar conditions. It works by relaxing the muscles and helping to restore the normal movement of the gut.

For adults, elderly and children over 10 years: Mebeverine Tablet: 1 tablet 03 times daily. Mebeverine 200 SR Capsule: 1 capsule 02 times daily. This is most effective when taken 20 minutes before meals. After several weeks when the desired effect has been obtained, the dosage may be gradually reduced.Missed dose: If a dose of this medicine is missed, that should be taken as soon as possible. However, if it is almost time for the next dose, then skip the missed dose and the regular dosing schedule should be maintained. Dose should not be doubled at the same time to compensate the missed dose.

For adults, elderly and children over 10 years: Colomeb 135 mg 135 mg tablet: 1 tablet 03 times daily. Colomeb 135 mg 200 mg capsule: 1 capsule 02 times daily. This is most effective when taken 20 minutes before meals. After several weeks when the desired effect has been obtained, the dosage may be gradually reduced.Missed dose: If a dose of this medicine is missed, that should be taken as soon as possible. However, if it is almost time for the next dose, then skip the missed dose and the regular dosing schedule should be maintained. Dose should not be doubled at the same time to compensate the missed dose.Use in children: Mebeverine is not recommended for children under 10 years.

Not known.

Hypersensitivity to the drug or any other ingredients.

Generally Mebeverine is well tolerated. However, few side-effects like skin rash, urticaria and angioedema may appear

No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised. Mebeverine does not excrete in the breast milk after administering the therapeutic dose.

Caution should be exercised in porphyria or allergic reaction to this or any other medicine of this group.

On theoretical grounds it may be predicted that CNS excitability will occur in case of overdosage. No specific antidote is known: gastric lavage and symptomatic treatment is recommended

Do not store above 30°C. Keep away from light and out of the reach of children.

Use in children: Mebeverine is not recommended in children under 10 years.

Anticholinergics

No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised. Mebeverine does not excrete in the breast milk after administering at therapeutic dose.